Transfusion-transmitted hepatitis B virus infection

J. Virol. Methods

1996 • 2,573 citations

Hepatitis B Virus Infection: Epidemiology and Vaccination

2006 • 1,113 citations

Statements from the Taormina expert meeting on occult hepatitis B virus infection

2008 • 789 citations

Current prevalence and incidence of infectious disease markers and estimated window‐period risk in the American Red Cross blood donor population

2002 • 666 citations

A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donors

2005 • 421 citations

Two Decades of Universal Hepatitis B Vaccination in Taiwan: Impact and Implication for Future Strategies

2007 • 338 citations

Occult hepatitis B virus infection: implications in transfusion

2004 • 304 citations

TRANSMISSION OF HEPATITIS B VIRUS FROM HEPATITIS B CORE ANTIBODY-POSITIVE DONORS IN LIVING RELATED LIVER TRANSPLANTS

1998 • 268 citations

The cost‐effectiveness of NAT for HIV, HCV, and HBV in whole‐blood donations

2003 • 267 citations

Comparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infection

2003 • 263 citations

Serological pattern ?anti-HBc alone?: Report on a workshop

2000 • 256 citations

Latent hepatitis B virus infection in healthy individuals with antibodies to hepatitis B core antigen

2000 • 235 citations

HBV DNA persistence 10 years after liver transplantation despite successful anti-HBS passive immunoprophylaxis

2003 • 230 citations

Genetic variability of the S gene of hepatitis B virus: clinical and diagnostic impact

2004 • 211 citations

Survey of hepatitis B surface variant infection in children 15 years after a nationwide vaccination programme in Taiwan

2004 • 210 citations

Infectivity of blood components with low hepatitis B virus DNA levels identified in a lookback program

2007 • 203 citations

Frequency of HBV DNA detection in US blood donors testing positive for the presence of anti‐HBc: implications for transfusion transmission and donor screening

2003 • 201 citations

Hepatitis B virus infection and transfusion medicine: science and the occult

2008 • 193 citations

Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus‐1, hepatitis C virus, and hepatitis B virus

2008 • 189 citations

The risk of hepatitis B virus infection by transfusion in Kumasi, Ghana

2003 • 182 citations

Current Risks of Transfusion-Transmitted Agents: A Review

2007 • 162 citations

International Forum: 1

2005 • 154 citations

Current incidence and estimated residual risk of transfusion‐transmitted infections in donations made to Canadian Blood Services

2007 • 152 citations

De novo and apparent de novo hepatitis B virus infection after liver transplantation

1997 • 145 citations

Donor screening for antibody to hepatitis B core antigen and hepatitis B virus infection in transfusion recipients

1995 • 140 citations

How I treat and monitor viral hepatitis B infection in patients receiving intensive immunosuppressive therapies or undergoing hematopoietic stem cell transplantation

2009 • 140 citations

Frequency and load of hepatitis B virus DNA in first-time blood donors with antibodies to hepatitis B core antigen

2002 • 140 citations

Predonation screening of blood donors with rapid tests: implementation and efficacy of a novel approach to blood safety in resource‐poor settings

2005 • 139 citations

Infection of human hepatocyte chimeric mouse with genetically engineered hepatitis B virus

2005 • 139 citations

A review of the long-term protection after hepatitis A and B vaccination

2006 • 133 citations

Impact of individual‐donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa

2009 • 132 citations

Epidemiology of HBV infection in Asian blood donors: Emphasis on occult HBV infection and the role of NAT

2006 • 129 citations

Characterization of occult hepatitis B virus from blood donors carrying genotype A2 or genotype D strains

2008 • 124 citations

Antibodies to hepatitis B surface antigen prevent viral reactivation in recipients of liver grafts from anti-HBC positive donors

2002 • 122 citations

Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti‐HBc: implications for future HBV screening policy

2004 • 122 citations

Anti-HBs positive occult hepatitis B virus carrier blood infectious in two transfusion recipients

2008 • 121 citations

Evidence that anti‐HBc but not HBV DNA testing may prevent some HBV transmission by transfusion

1999 • 119 citations

Assessing the impact of HBV NAT on window period reduction and residual risk

2006 • 115 citations

Transmission of occult hepatitis B virus by transfusion to adult and pediatric recipients in Taiwan

2005 • 109 citations

Evaluation of rapid diagnostic tests for the detection of human immunodeficiency virus types 1 and 2, hepatitis B surface antigen, and syphilis in Ho Chi Minh City, Vietnam.

2000 • 108 citations

Characterization of HBV DNA+/HBsAg− blood donors in Poland identified by triplex NAT

2006 • 106 citations

Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus

2005 • 105 citations

Hepatitis B virus (HBV) DNA screening of blood donations in minipools with the COBAS AmpliScreen HBV test

2005 • 105 citations

Italian blood donors with anti-HBc and occult hepatitis B virus infection

2007 • 105 citations

Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors?

2004 • 103 citations

Estimates of the frequency of HBV, HCV, and HIV infectious donations entering the blood supply in the United Kingdom, 1996 to 2003

2005 • 99 citations

Functional analysis of hepatitis B virus reactivating in hepatitis B surface antigen-negative individuals

2005 • 98 citations

Human immunodeficiency virus, hepatitis C and hepatitis B infections among blood donors in Germany 2000-2002: risk of virus transmission and the impact of nucleic acid amplification testing

2005 • 96 citations

Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6‐year survey

2008 • 96 citations

Frequent presence of HBV in the sera of HBsAg‐negative, anti‐HBc‐positive blood donors

2001 • 96 citations

Coexistence of Hepatitis B Surface Antigen (HBsAg) and Heterologous Subtype-Specific Antibodies to HBsAg among Patients with Chronic Hepatitis B Virus Infection

2007 • 96 citations

Hepatitis B virus blood screening: unfinished agendas

2006 • 94 citations

A method for estimating hepatitis B virus incidence rates in volunteer blood donors. National Heart, Lung, and Blood Institute Retrovirus Epidemiology Donor Study

1997 • 90 citations

Minimum infectious dose of hepatitis B virus in chimpanzees and difference in the dynamics of viremia between genotype A and genotype C

2007 • 88 citations

Transfusion‐transmitted HBV infection in an endemic area: the necessity of more sensitive screening for HBV carriers

2002 • 85 citations

Characterization of occult hepatitis B virus strains in south african blood donors

2009 • 79 citations

Evaluation of 17 CE-marked HBsAg assays with respect to clinical sensitivity, analytical sensitivity, and hepatitis B virus mutant detection

2006 • 75 citations

Infectivity of blood from PCR‐positive, HBsAg‐negative, anti‐HBs‐positive cases of resolved hepatitis B infection

2001 • 73 citations

Detection of HBs antigen in “anti-HBc alone” positive sera

1994 • 72 citations

Residual risk of transfusion‐transmitted viral infections in Shenzhen, China, 2001 through 2004

2007 • 71 citations

Anti‐HBc screening of blood donors: a comparison of nine anti‐HBc tests

2006 • 70 citations

Comparison of the sensitivity of NAT using pooled donor samples for HBV and that of a serologic HBsAg assay

2001 • 68 citations

Analysis of HBV infection after blood transfusion in Japan through investigation of a comprehensive donor specimen repository

2001 • 68 citations

Lengths of hepatitis B viremia and antigenemia in blood donors: preliminary evidence of occult (hepatitis B surface antigen–negative) infection in the acute stage

2007 • 67 citations

Comparison of two automated nucleic acid testing systems for simultaneous detection of human immunodeficiency virus and hepatitis C virus RNA and hepatitis B virus DNA

2007 • 67 citations

Long‐term surveillance of haematopoietic stem cell recipients with resolved hepatitis B: high risk of viral reactivation even in a recipient with a vaccinated donor

2006 • 66 citations

A comparison of hepatitis B seroepidemiology in ten European countries

2008 • 64 citations

A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus

2008 • 64 citations

High frequency of hepatitis B virus infection in patients with β‐thalassemia receiving multiple transfusions

2003 • 64 citations

HBsAg non-reactive HBV infection in blood donors: Transmission and pathogenicity

2007 • 63 citations

Multicenter evaluation of individual donor nucleic acid testing (NAT) for simultaneous detection of human immunodeficiency virus -1 & hepatitis B & C viruses in Indian blood donors.

2008 • 63 citations

Hepatitis B virus genotype G monoinfection and its transmission by blood components

2006 • 61 citations

Breakthrough of hepatitis B virus escape mutants after vaccination and virus reactivation

2006 • 61 citations

Titration of hepatitis B virus infectivity in the sera of pre‐acute and late acute phases of HBV infection: Transmission experiments to chimeric mice with human liver repopulated hepatocytes

2008 • 59 citations

Low‐level viraemia of hepatitis B virus in an anti‐HBc‐ and anti‐HBs‐positive blood donor

2004 • 58 citations

An estimate of the current risk of transmitting blood‐borne infections through blood transfusion in Italy

2002 • 58 citations

Can the serological status of “anti‐HBc alone” be considered a sentinel marker for detection of “occult” HBV infection?

2008 • 57 citations

Hepatitis B virus DNA–positive, hepatitis B surface antigen–negative blood donations intercepted by anti‐hepatitis B core antigen testing: the Canadian Blood Services experience

2007 • 56 citations

Transmission of serologically silent hepatitis B virus along with hepatitis C virus in two cases of posttransfusion hepatitis

1992 • 54 citations

Surveillance of risk profiles among new and repeat blood donors with transfusion‐transmissible infections from 1995 through 2003 in the Netherlands

2006 • 53 citations

Evaluation of Two New Automated Assays for Hepatitis B Virus Surface Antigen (HBsAg) Detection: IMMULITE HBsAg and IMMULITE 2000 HBsAg

2003 • 52 citations

Residual risk of transfusion-transmitted viral infections in Spain, 1997-2002, and impact of nucleic acid testing

2005 • 52 citations

Significance of Isolated Hepatitis B Core Antibody in Blood Donors

1993 • 52 citations

Evaluation of the performance of four rapid tests for detection of hepatitis B surface antigen in Antananarivo, Madagascar

2008 • 49 citations

Detection and characterization of hepatitis B virus of anti‐hepatitis B core antigen–reactive blood donors in Quebec with an in‐house nucleic acid testing assay

2007 • 49 citations

Significance of isolated hepatitis B core antibody in blood donors from São Paulo

2001 • 48 citations

Impact of hepatitis B vaccination on hepatitis B disease and nucleic acid testing in high-prevalence populations

2006 • 44 citations

Incidence of viral markers and evaluation of the estimated risk in the Swiss blood donor population from 1996 to 2003

2005 • 44 citations

Quantification of hepatitis B virus genomes and infectivity in human serum samples

2006 • 43 citations

Waning‐off effect of serum hepatitis B surface antibody amongst Taiwanese university students: 18 years post‐implementation of Taiwan’s national hepatitis B vaccination programme

2007 • 43 citations

The German experience with NAT

2002 • 39 citations

Frequency and significance of antibodies against hepatitis B core (anti-HBc) antigen as the only serological marker for hepatitis B infection in Lebanese blood donors

2005 • 39 citations

Evidence of acute primary occult hepatitis B virus infection in an Italian repeat blood donor

2009 • 34 citations

Variants within the "a" Determinant of HBs Gene in Children and Adolescents with and without Hepatitis B Vaccination as Part of Thailand's Expanded Program on Immunization (EPI).

2001 • 34 citations

Hepatitis B virus (HBV) screening strategy to ensure the safety of blood for transfusion through a combination of immunological testing and nucleic acid amplification testing — Japanese experience

2006 • 31 citations

Evaluation of a multiplex human immunodeficiency virus‐1, hepatitis C virus, and hepatitis B virus nucleic acid testing assay to detect viremic blood donors in northern Thailand

2007 • 30 citations

Prevention of de novo HBV infection by the presence of anti-HBs in transplanted patients receiving core antibody-positive livers

2006 • 30 citations

Hepatitis B vaccinees may be mistaken for confirmed hepatitis B surface antigen‐positive blood donors

2002 • 30 citations

Transfusion‐transmitted hepatitis B virus infection in the UK: a small and moving target

2002 • 30 citations

A novel hepatitis B virus surface antigen immunoassay as sensitive as hepatitis B virus nucleic acid testing in detecting early infection

2008 • 30 citations

Analysis of voluntary blood donors with biologic false reactivity on chemiluminescent immunoassays and implications for donor management

2003 • 30 citations

Quality of life of hepatitis B and C patients after liver transplantation

1997 • 30 citations

Hepatitis A and B virus markers in immune serum globulin

1980 • 29 citations

Evaluation of COBAS AmpliPrep nucleic acid extraction in conjunction with COBAS AmpliScreen HBV DNA, HCV RNA and HIV‐1 RNA amplification and detection

2005 • 27 citations

Hepatitis B virus genotype E surface antigen detection with different immunoassays and diagnostic impact of mutations in the preS/S gene

2007 • 26 citations

A probable case of hepatitis B virus transfusion transmission revealed after a 13‐month‐long window period

2008 • 26 citations

The EASTR study: a new approach to determine the reasons for transfusion in epidemiological studies

2009 • 22 citations

Prevention of de novo hepatitis B infection after liver transplantation with allografts from hepatitis B core antibody positive donors.

2000 • 22 citations

Risk assessment and cost-effectiveness/utility analysis

2009 • 20 citations

Analytical and clinical sensitivity of the Procleix Ultrio HIV‐1/HCV/HBV assay in samples with a low viral load

2006 • 19 citations

Hepatitis B virus traceback and lookback: factors to consider

2008 • 18 citations

HBV vaccination of HCV-infected patients with occult HBV infection and anti-HBc-positive blood donors

2006 • 18 citations

Hepatitis B virus infection after renal transplantation in the presence of antibody to hepatitis B surface antigen immunity

2004 • 16 citations

A revised method for estimating hepatitis B virus transfusion residual risk based on antibody to hepatitis B core antigen incident cases

2008 • 15 citations

Benefits of a blood donation archive repository: international survey of donor repository procedures and Scottish experiences

2007 • 10 citations

Monitoring viral incidence rates: tools for the implementation of European Union regulations

2009 • 7 citations

A Simple Strategy to Look Back on Posttransfusion Hepatitis B in a Multitransfused Patient

1998 • 6 citations

Deleted Work

1955 • 0 citations